Skip to content

24/7 dementia helpline 800-272-3900

Dementia Today

Drug Patch Gets OK for Severe Alzheimer’s

Dementia TodayPublished June 30, 20132 min read

Key points

  • The FDA has expanded the indication for transdermal rivastigmine to include patients with severe Alzheimer’s disease.
  • Supporting evidence for the expanded approval came from a randomized trial comparing the highest approved dosage of transdermal rivastigmine (13 mg/24 hr) and the lowest approved dosage (4.6 mg/24 hr).
  • The two groups did not differ with respect to scores on the neuropsychiatric inventory.
  • Discontinuation because of adverse events and serious adverse events occurred more frequently in the high-dose group (13.5% versus 10.9% and 8.2% versus 4.5%, respectively).

The FDA has expanded the indication for transdermal rivastigmine to include patients with severe Alzheimer’s disease.

The approval means that the transdermal agent is indicated for use in any Alzheimer’s patient, irrespective of disease stage or severity. The expanded indication is the first of its type for any Alzheimer’s drug, according to a statement from drug manufacturer Novartis.

Supporting evidence for the expanded approval came from a randomized trial comparing the highest approved dosage of transdermal rivastigmine (13 mg/24 hr) and the lowest approved dosage (4.6 mg/24 hr). The trial involved 716 patients with severe Alzheimer’s disease, associated with a Mini-Mental State Examination score of 3 to 12.

The 24-week assessment showed significantly less deterioration in activities of daily living scale and the severe impairment test battery in patients who received the high-dose patch (P=0.0247, P<0.0001). Additionally, the high-dose group had significantly greater improvement in the clinical global impression of change assessment (P=0.0023).

The two groups did not differ with respect to scores on the neuropsychiatric inventory.

Adverse events and severe adverse events occurred in a similar proportion of patients in the two treatment arms (74.6% high-dose versus 73.3% low-dose for adverse events, and 14.9% versus 13.6% for severe adverse events).

Discontinuation because of adverse events and serious adverse events occurred more frequently in the high-dose group (13.5% versus 10.9% and 8.2% versus 4.5%, respectively).

Results of the randomized trial were reported earlier this year at the American Academy of Neurology and the American Association for Geriatric Psychiatry meetings.

###

By Charles Bankhead, Staff Writer, MedPage Today

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If a person with dementia is missing, injured or in danger, call 911 or your local emergency number.

Filed underDementia News

Worried about memory changes?

Normal aging, or an early warning sign?

Ten common changes, each set beside what is typical with age. Tick what you have noticed and see what to do next.

Open the 10-sign checklist

Getting help

Sudden changes are not just the dementia.

Dementia usually changes slowly. A sharp change over hours or days can mean an infection, delirium, a stroke or a medication problem, and needs a doctor the same day. Call 911 or your local emergency number if you see any of these:

  • Confusion that comes on suddenly, over hours or days
  • Face drooping, arm weakness or slurred speech
  • A fall, a head injury or new severe pain
  • Very drowsy or hard to wake

The free Alzheimer’s Association Helpline answers questions about memory loss, diagnosis and caregiving, day and night, in more than 200 languages (US).

If someone with dementia is missing

  1. STEP 115 minSearch close by firstCheck the house, garden, car and the places the person often walks to. Don’t spend longer than about 15 minutes.
  2. STEP 2911Then call for helpTell the operator the person has dementia and is a vulnerable adult. Police treat this as urgent.
  3. STEP 3PhotoHave details readyA recent photo, what they were wearing, medical conditions and places they used to live or work.

Based on Alzheimer’s Association guidance on wandering. Outside the US, call your local emergency number.